Published in Cardiovasc Res on May 01, 2002
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50
Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol (2010) 3.18
Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation (2008) 2.72
Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation (2010) 2.57
Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm (2010) 2.42
Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart (2004) 2.23
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol (2013) 1.96
Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res (2010) 1.74
Repolarization and activation restitution near human pulmonary veins and atrial fibrillation initiation: a mechanism for the initiation of atrial fibrillation by premature beats. J Am Coll Cardiol (2008) 1.71
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res (2011) 1.65
TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation. Circ Res (2010) 1.65
The ionic bases of the action potential in isolated mouse cardiac Purkinje cell. Heart Rhythm (2012) 1.59
Gene expression and genetic variation in human atria. Heart Rhythm (2013) 1.50
Systems biology and the virtual physiological human. Mol Syst Biol (2009) 1.48
Inhibition of platelet-derived growth factor-AB signaling prevents electromechanical remodeling of adult atrial myocytes that contact myofibroblasts. Heart Rhythm (2013) 1.45
Novel molecular targets for atrial fibrillation therapy. Nat Rev Drug Discov (2012) 1.42
Expression changes of ionic channels in early phase of cultured rat atrial myocytes induced by rapid pacing. J Cardiothorac Surg (2013) 1.42
Atrial fibrillation and microRNAs. Front Physiol (2014) 1.31
Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. Am J Physiol Heart Circ Physiol (2006) 1.20
Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing. Br J Pharmacol (2010) 1.08
Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation. Circulation (2014) 1.07
Obstructive sleep apnea and cardiac arrhythmias. Ann Thorac Med (2010) 1.03
Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant. J Cardiovasc Electrophysiol (2011) 1.03
Pulmonary vein ablation for idiopathic atrial fibrillation: six month outcome of first procedure in 100 consecutive patients. Heart (2005) 1.02
Critical mass hypothesis revisited: role of dynamical wave stability in spontaneous termination of cardiac fibrillation. Am J Physiol Heart Circ Physiol (2005) 1.01
Redox regulation, NF-kappaB, and atrial fibrillation. Antioxid Redox Signal (2009) 1.01
A distinct de novo expression of Nav1.5 sodium channels in human atrial fibroblasts differentiated into myofibroblasts. J Physiol (2012) 1.00
Mechanisms of sinoatrial node dysfunction in a canine model of pacing-induced atrial fibrillation. Heart Rhythm (2009) 1.00
The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation. Vasc Health Risk Manag (2011) 0.99
The slow force response to stretch in atrial and ventricular myocardium from human heart: functional relevance and subcellular mechanisms. Prog Biophys Mol Biol (2008) 0.97
Expression of heat shock proteins in myocardium of patients with atrial fibrillation. Cell Stress Chaperones (2007) 0.96
Triggers and anatomical substrates in the genesis and perpetuation of atrial fibrillation. Curr Cardiol Rev (2012) 0.95
n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling. Br J Pharmacol (2006) 0.95
Atrial Fibrillation associated chromosome 4q25 variants are not associated with PITX2c expression in human adult left atrial appendages. PLoS One (2014) 0.94
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm (2016) 0.94
The future of atrial fibrillation therapy: intervention on heat shock proteins influencing electropathology is the next in line. Neth Heart J (2015) 0.94
Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation. J Cardiovasc Electrophysiol (2013) 0.93
Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.92
Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. J Am Heart Assoc (2014) 0.91
Transmural characteristics of atrial fibrillation in canine models of structural and electrical atrial remodeling assessed by simultaneous epicardial and endocardial mapping. Heart Rhythm (2010) 0.90
A novel double cryoballoon strategy in persistent atrial fibrillation: a pilot study. Clin Res Cardiol (2012) 0.90
Atrial selectivity of antiarrhythmic drugs. J Physiol (2013) 0.89
Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation. J Am Heart Assoc (2014) 0.89
Sleep apnea and atrial fibrillation; 2012 update. Curr Cardiol Rev (2012) 0.88
Antioxidant vitamins in the prevention of atrial fibrillation: what is the evidence? Cardiol Res Pract (2011) 0.88
Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation. BMC Cardiovasc Disord (2011) 0.87
Rationale and current perspective for early rhythm control therapy in atrial fibrillation. Europace (2011) 0.87
Chronic atrial fibrillation causes left ventricular dysfunction in dogs but not goats: experience with dogs, goats, and pigs. Am J Physiol Heart Circ Physiol (2013) 0.86
Echocardiographic measures of cardiac structure and function are associated with risk of atrial fibrillation in blacks: the Atherosclerosis Risk in Communities (ARIC) study. PLoS One (2014) 0.86
Diverse Fibrosis Architecture and Premature Stimulation Facilitate Initiation of Reentrant Activity Following Chronic Atrial Fibrillation. J Cardiovasc Electrophysiol (2015) 0.86
The effects of wenxin keli on p-wave dispersion and maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med (2013) 0.85
Beat shock proteins and atrial fibrillation. Cell Stress Chaperones (2007) 0.85
Quantification of the functional consequences of atrial fibrillation and surgical ablation on the left atrium using cardiac magnetic resonance imaging. Eur J Cardiothorac Surg (2014) 0.85
Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study. Circ Cardiovasc Imaging (2015) 0.85
Prevention of immediate recurrence of atrial fibrillation with low-dose landiolol after radiofrequency catheter ablation. J Arrhythm (2015) 0.85
In silico screening of the key cellular remodeling targets in chronic atrial fibrillation. PLoS Comput Biol (2014) 0.84
AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts. PLoS One (2014) 0.83
Loss of proteostatic control as a substrate for atrial fibrillation: a novel target for upstream therapy by heat shock proteins. Front Physiol (2012) 0.83
Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation. J Interv Card Electrophysiol (2011) 0.83
[New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers]. Herzschrittmacherther Elektrophysiol (2006) 0.83
Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker. J Am Heart Assoc (2013) 0.83
Attenuation of acetylcholine activated potassium current (I KACh) by simvastatin, not pravastatin in mouse atrial cardiomyocyte: possible atrial fibrillation preventing effects of statin. PLoS One (2014) 0.82
Different subcellular populations of L-type Ca2+ channels exhibit unique regulation and functional roles in cardiomyocytes. J Mol Cell Cardiol (2011) 0.81
A POINT-CORRESPONDENCE APPROACH TO DESCRIBING THE DISTRIBUTION OF IMAGE FEATURES ON ANATOMICAL SURFACES, WITH APPLICATION TO ATRIAL FIBRILLATION. Proc IEEE Int Symp Biomed Imaging (2013) 0.81
Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system. Front Physiol (2012) 0.81
Obstructive sleep apnea and atrial fibrillation. Nat Sci Sleep (2010) 0.81
Relation of gender and interatrial dyssynchrony on tissue Doppler imaging to the prediction of the progression to chronic atrial fibrillation in patients with nonvalvular paroxysmal atrial fibrillation. Heart Vessels (2010) 0.81
Ablation of complex fractionated atrial electrograms in catheter ablation for AF; where have we been and where are we going? Curr Cardiol Rev (2012) 0.80
Fibrosis and electrophysiological characteristics of the atrial appendage in patients with atrial fibrillation and structural heart disease. J Interv Card Electrophysiol (2013) 0.80
Regional left atrial interstitial remodeling in patients with chronic atrial fibrillation undergoing mitral-valve surgery. Virchows Arch (2004) 0.80
The Contribution of Ionic Currents to Rate-Dependent Action Potential Duration and Pattern of Reentry in a Mathematical Model of Human Atrial Fibrillation. PLoS One (2016) 0.80
Wall-motion based analysis of global and regional left atrial mechanics. IEEE Trans Med Imaging (2013) 0.80
Frequent periodic leg movement during sleep is an unrecognized risk factor for progression of atrial fibrillation. PLoS One (2013) 0.80
Evaluation of left atrial functions by color tissue Doppler imaging in adults with body mass indexes >or=30 kg/m(2) versus those <30 kg/m (2). Int J Cardiovasc Imaging (2008) 0.80
Dynamics factors preceding the initiation of atrial fibrillation in humans. Heart Rhythm (2008) 0.79
Atrial Strain and Strain Rate: A Novel Method for the Evaluation of Atrial Stunning. Arq Bras Cardiol (2016) 0.79
Association between reversal in the expression of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel and age-related atrial fibrillation. Med Sci Monit (2014) 0.79
Atrial fibrillation complicated by heart failure induces distinct remodeling of calcium cycling proteins. PLoS One (2015) 0.79
Can we ablate permanent atrial fibrillation? Heart (2005) 0.79
Patient-specific flexible and stretchable devices for cardiac diagnostics and therapy. Prog Biophys Mol Biol (2014) 0.79
Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal. Cardiovasc Res (2016) 0.79
Whole blood gene expression and atrial fibrillation: the Framingham Heart Study. PLoS One (2014) 0.79
Effects of selective mineralocorticoid receptor antagonism on atrial ion currents and early ionic tachycardia-induced electrical remodelling in rabbits. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.78
Effect of rosuvastatin on atrial structural remodeling in rabbits with myocardial infarction. Biomed Rep (2014) 0.78
Efficacy of the maze procedure for atrial fibrillation associated with atrial septal defect. Korean J Thorac Cardiovasc Surg (2013) 0.78
Expression profile analysis of circulating microRNAs and their effects on ion channels in Chinese atrial fibrillation patients. Int J Clin Exp Med (2015) 0.78
Angiotensin receptor blockers and statins could alleviate atrial fibrosis via regulating platelet-derived growth factor/Rac1/nuclear factor-kappa B Axis. Int J Med Sci (2013) 0.78
MDCT in the diagnostic algorithm in patients with symptomatic atrial fibrillation. World J Radiol (2011) 0.78
A new role for extracellular Ca2+ in gap-junction remodeling: studies in humans and rats. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.78
Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation. BMC Cardiovasc Disord (2014) 0.78
Protein analysis of atrial fibrosis via label-free proteomics in chronic atrial fibrillation patients with mitral valve disease. PLoS One (2013) 0.78
Prognostic Implications of Right and Left Atrial Enlargement after Radiofrequency Catheter Ablation in Patients with Nonvalvular Atrial Fibrillation. Korean Circ J (2015) 0.78
Effects of Heterogeneous Diffuse Fibrosis on Arrhythmia Dynamics and Mechanism. Sci Rep (2016) 0.78
Accelerated fibrosis and apoptosis with ageing and in atrial fibrillation: Adaptive responses with maladaptive consequences. Exp Ther Med (2013) 0.78
Early management of atrial fibrillation: from imaging to drugs to ablation. Nat Rev Cardiol (2010) 0.78
[Molecular biology of the heart atrium. New insights into the pathophysiology of atrial fibrillation as well as its clinical implications]. Z Kardiol (2004) 0.78
Applying harmonic optical microscopy for spatial alignment of atrial collagen fibers. PLoS One (2010) 0.77
Non-antiarrhythmic medications for atrial fibrillation: from bench to clinical practice. J Interv Card Electrophysiol (2008) 0.77
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31
Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. J Clin Invest (2009) 3.45
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J (2016) 2.70
PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ Cardiovasc Genet (2011) 2.56
Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough. Circulation (2010) 2.56
Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol (2010) 2.51
Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation (2012) 1.81
Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation (2011) 1.62
Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability. Heart Rhythm (2010) 1.59
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. Europace (2011) 1.57
Atrial ultrastructural changes during experimental atrial tachycardia depend on high ventricular rate. J Cardiovasc Electrophysiol (2004) 1.57
Mechanoelectrical coupling enhances initiation and affects perpetuation of atrial fibrillation during acute atrial dilation. Heart Rhythm (2010) 1.54
Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol (2006) 1.51
Combined blockade of early and late activated atrial potassium currents suppresses atrial fibrillation in a pig model of obstructive apnea. Heart Rhythm (2011) 1.43
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace (2016) 1.39
Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension (2012) 1.35
Time course and mechanisms of endo-epicardial electrical dissociation during atrial fibrillation in the goat. Cardiovasc Res (2010) 1.33
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand. Circulation (2003) 1.15
Post-operative atrial fibrillation: a maze of mechanisms. Europace (2011) 1.12
Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. Hypertension (2012) 1.09
Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J Mol Cell Cardiol (2008) 1.09
Alterations of atrial Ca(2+) handling as cause and consequence of atrial fibrillation. Cardiovasc Res (2010) 1.06
Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm (2011) 1.06
Paroxysmal atrial fibrillation: just a matter of nerves? Heart Rhythm (2006) 1.06
Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat. J Am Coll Cardiol (2006) 1.06
Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res (2002) 1.05
Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ Arrhythm Electrophysiol (2010) 1.05
Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology. J Med Chem (2005) 1.04
Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension (2013) 1.03
Loss of continuity in the thin epicardial layer because of endomysial fibrosis increases the complexity of atrial fibrillatory conduction. Circ Arrhythm Electrophysiol (2013) 1.01
Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria. Prog Biophys Mol Biol (2008) 1.01
The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol (2009) 1.01
Re-expression of alpha skeletal actin as a marker for dedifferentiation in cardiac pathologies. J Cell Mol Med (2009) 1.01
Transmural conduction is the predominant mechanism of breakthrough during atrial fibrillation: evidence from simultaneous endo-epicardial high-density activation mapping. Circ Arrhythm Electrophysiol (2013) 1.00
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J (2009) 1.00
Fibrillatory conduction in the atrial free walls of goats in persistent and permanent atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 0.99
Miconazole induces changes in actin cytoskeleton prior to reactive oxygen species induction in yeast. J Biol Chem (2007) 0.99
Reconstruction of instantaneous phase of unipolar atrial contact electrogram using a concept of sinusoidal recomposition and Hilbert transform. IEEE Trans Biomed Eng (2014) 0.95
Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study. Br J Clin Pharmacol (2012) 0.95
Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.94
Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice. Int J Cardiol (2011) 0.93
Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. J Clin Invest (2014) 0.93
Management of atrial fibrillation in patients with heart failure. Eur Heart J (2007) 0.93
Effects of electrical stimulation of carotid baroreflex and renal denervation on atrial electrophysiology. J Cardiovasc Electrophysiol (2013) 0.90
Gene therapy for repair of cardiac fibrosis: a long way to Tipperary. Circulation (2005) 0.89
Dynamic remodeling of intracellular Ca²⁺ signaling during atrial fibrillation. J Mol Cell Cardiol (2013) 0.88
Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation. J Cardiovasc Electrophysiol (2008) 0.88
Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway. J Mol Cell Cardiol (2008) 0.88
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thromb Haemost (2011) 0.87
Analysis of altered gene expression during sustained atrial fibrillation in the goat. Cardiovasc Res (2002) 0.86
Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat. Circulation (2005) 0.86
Troponin I isoform expression in human and experimental atrial fibrillation. Circulation (2004) 0.86
Stability of complex fractionated atrial electrograms: a systematic review. J Cardiovasc Electrophysiol (2012) 0.85
Renal denervation: effects on atrial electrophysiology and arrhythmias. Clin Res Cardiol (2014) 0.84
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg (2016) 0.82
Identification of Rotors during Human Atrial Fibrillation Using Contact Mapping and Phase Singularity Detection: Technical Considerations. IEEE Trans Biomed Eng (2016) 0.82
Synergistic action of atrial dilation and sodium channel blockade on conduction in rabbit atria. J Cardiovasc Electrophysiol (2004) 0.81
A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent. Dermatology (2007) 0.81
Xenon does not impair the responsiveness of cardiac muscle bundles to positive inotropic and chronotropic stimulation. Anesthesiology (2002) 0.80
Oral prucalopride in children with functional constipation. J Pediatr Gastroenterol Nutr (2013) 0.80
Rotors and breakthroughs as three-dimensional perpetuators of atrial fibrillation. Cardiovasc Res (2012) 0.80
The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob Agents Chemother (2004) 0.80
Atrial supply-demand balance in healthy adult pigs: coronary blood flow, oxygen extraction, and lactate production during acute atrial fibrillation. Cardiovasc Res (2013) 0.80
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. Rev Esp Cardiol (Engl Ed) (2017) 0.80
Dedifferentiation of atrial cardiomyocytes: from in vivo to in vitro. Cardiovasc Res (2002) 0.79
Inhibitors of the Na+/H+ exchanger cannot prevent atrial electrical remodeling in the goat. J Cardiovasc Electrophysiol (2004) 0.79
Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants. Cardiovasc Res (2014) 0.79
Rearrangement of atrial bundle architecture and consequent changes in anisotropy of conduction constitute the 3-dimensional substrate for atrial fibrillation. Circ Arrhythm Electrophysiol (2013) 0.78
In vitro activity of R126638 and ketoconazole against Malassezia species. Acta Derm Venereol (2006) 0.78
Efficacy of a single oral dose of 200 mg pramiconazole in vulvovaginal yeast infections: an exploratory phase IIa trial. Acta Derm Venereol (2008) 0.78
A computer model of endo-epicardial electrical dissociation and transmural conduction during atrial fibrillation. Europace (2012) 0.78
Long-term changes in sequence of atrial activation and refractory periods: no evidence for "atrial memory". Heart Rhythm (2005) 0.77
Design and synthesis of a series of piperazine-1-carboxamidine derivatives with antifungal activity resulting from accumulation of endogenous reactive oxygen species. ChemMedChem (2009) 0.77
AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat. Circulation (2006) 0.77
Identification of Rotors during Human Atrial Fibrillation using Contact Mapping and Phase Singularity Detection: Technical Considerations. IEEE Trans Biomed Eng (2016) 0.76
Effects of renal denervation on atrial arrhythmogenesis. Future Cardiol (2014) 0.76
The need for standardization of time- and frequency-domain analysis of body surface electrocardiograms for assessment of the atrial fibrillation substrate. Europace (2012) 0.76
Enhanced late na(+) currents in atrial fibrillation new drug target or just an epiphenomenon? J Am Coll Cardiol (2010) 0.76
Hypertension begets hypertrophy begets atrial fibrillation? Insights from yet another sheep model. Eur Heart J (2006) 0.76
Is NOS uncoupling the missing link between atrial fibrillation and chronic non-ischaemic cardiomyopathy? Cardiovasc Res (2011) 0.75
Leaky ryanodine receptors in the failing heart: the root of all evil? Cardiovasc Res (2011) 0.75
Effect of prucalopride on the pharmacokinetics of oral contraceptives in healthy women. Drugs R D (2013) 0.75
Inhibition of angiotensin II type 1 receptors reduces atrial stunning and spontaneous echo contrast after electrical cardioversion of atrial fibrillation. Eur Heart J (2006) 0.75
[2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS]. Kardiol Pol (2016) 0.75
Mapping of atrial fibrillation--basic research and clinical applications. Swiss Med Wkly (2009) 0.75
Far-field effect in unipolar electrograms revisited: High-density mapping of atrial fibrillation in humans. Conf Proc IEEE Eng Med Biol Soc (2015) 0.75
Recurrence quantification analysis applied to spatiotemporal pattern analysis in high-density mapping of human atrial fibrillation. Conf Proc IEEE Eng Med Biol Soc (2015) 0.75
Atrial fibrillatory wall motion and degree of atrial remodeling in patients with atrial fibrillation: a tissue velocity imaging study. J Cardiovasc Electrophysiol (2009) 0.75